Becton, Dickinson and Company
$196.38
+1.22 · +0.63% today
Market open · updated 12:44:26 PM ET
- High
- $197.62 5:00 AM
- Low
- $196.90 4:45 AM
Against the S&P 500 Price change through Oct 28, 2026
BDX+27.92%
S&P 500+13.26%
BDX+34.76%
S&P 500+12.41%
BDX−1.33%
S&P 500+88.06%
BDX+6.62%
S&P 500+68.51%
Key numbers
- Previous close
- $195.16
- Open
- $197.31
- Day's range
- $194.53 – $197.35
- 52-week range
- $127.59 – $200.47
- Volume
- 452,718
- Average volume
- 1.9 million
- Market value
- $53.5 billion
- Price to earnings
- 58.8last 12 months
- Earnings per share
- $3.42last 12 months
- Beta
- 0.28moves less than the market
- Dividend
- $3.98 a year · 2.04%
- 50-day average
- $186.18
- 200-day average
- $165.61
Thursday, Nov 5, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Becton, Dickinson and sells to and competes with From our value chain
Becton, Dickinson and in the news
No desk stories on BDX yet. When we write about it, the story leads this list.
- HeadlineBD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment OptionsPRNewsWire · October 28, 2026 at 6:50 AM ET
- HeadlineFirst Eagle U.S. Value Fund Q3 2026 Portfolio ReviewSeeking Alpha · October 26, 2026 at 12:30 PM ET
- HeadlineBDX Stock Gains 25.5% in Six Months: What's Behind the Rally?Zacks Investment Research · October 22, 2026 at 3:26 PM ET
- HeadlineBD's Revello Stent Shows Strong AGILITY Trial Results for PAD PatientsZacks Investment Research · October 15, 2026 at 2:25 PM ET
- CongressRo Khanna bought $1,001 - $15,000 of BDXHouse filing · disclosed Oct 9, 2026
- CongressThomas Kean sold $1,001 - $15,000 of BDXHouse filing · disclosed Jun 19, 2026
- CongressKevin Hern sold $15,001 - $50,000 of BDXHouse filing · disclosed Apr 6, 2026
- CongressRo Khanna bought $1,001 - $15,000 of BDXHouse filing · disclosed Oct 3, 2025
Earnings
Next report: Thursday, Nov 5, 2026, before the open.
Congress trades in BDX
5 purchases and 3 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 11, 2026 | Oct 9, 2026 |
| Thomas KeanHouse · R-New Jersey | Sale | $1,001 - $15,000 | May 21, 2026 | Jun 19, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $15,001 - $50,000 | Mar 17, 2026 | Apr 6, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 29, 2025 | Oct 3, 2025 |
| Lisa McClainHouse · R-Michigan | Sale | $1,001 - $15,000 | Jun 24, 2025 | Aug 13, 2025 |
| Lisa McClainHouse · R-Michigan | Purchase | $1,001 - $15,000 | Jun 17, 2025 | Aug 13, 2025 |
| Thomas H. KeanHouse | Purchase | $1,001 - $15,000 | May 13, 2025 | Jun 18, 2025 |
| Rob BresnahanHouse | Purchase | $1,001 - $15,000 | May 15, 2025 | Jun 10, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Becton, Dickinson and
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 72,000
- Headquarters
- Franklin Lakes, New Jersey
- Website
- bd.com
- Listed
- Feb 21, 1973
More medical - instruments & supplies stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.